| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| POLA1 |
1-[(3S,10R,13R,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy]-ethane-1,2-diol |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
(3S,10R,13R,17R)-17-((E)-(1R,4S)-4-Ethyl-1,5-dimethyl-hex-2-enyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
(beta-D-2'',3''-dideoxy-5''-F-cytidine-5''-triphosphate) |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
(9R)-9-[(dimethylsulfamoyl)(methyl)amino]-N-[(4-fluorophenyl)methyl]-3-hydroxy-4-oxo-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidine-2-carboxamide |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
Remdesivir triphosphate |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
Cholesterol |
NA |
500000 |
NA |
NA |
NA |
NA |
PubChem|TTD |
| POLA1 |
Cholestanol |
NA |
500000 |
NA |
NA |
NA |
NA |
PubChem|TTD |
| POLA1 |
2-[(3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethylhexyl)-10,13-dimethylhexadecahydrocyclopenta[a]phenanthren-3-yloxy]ethanol |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
[[(2R,3R,4R,5R)-4-chloro-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
1-[[(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]ethane-1,2-diol |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLA1 |
N-[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]acetamide |
NA |
NA |
NA |
500000 |
NA |
NA |
TTD |
| POLA1 |
(2S)-1-acetyl-N-[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]pyrrolidine-2-carboxamide |
NA |
NA |
NA |
500000 |
NA |
NA |
TTD |
| POLA1 |
[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-N-benzoylphosphonamidic acid |
NA |
NA |
NA |
500000 |
NA |
NA |
TTD |
| POLA1 |
[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-N-(pyridine-3-carbonyl)phosphonamidic acid |
NA |
NA |
NA |
250000 |
NA |
NA |
BindingDB|TTD |
| POLA1 |
[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-N-(pyridine-4-carbonyl)phosphonamidic acid |
NA |
NA |
NA |
500000 |
NA |
NA |
TTD |
| POLA1 |
N-[(2S)-1-acetylpyrrolidine-2-carbonyl]-[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy]phosphonamidic acid |
NA |
NA |
NA |
410000 |
NA |
NA |
BindingDB|TTD |
| POLA1 |
N-[(2S)-2-acetamido-3-phenylpropanoyl]-[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy]phosphonamidic acid |
NA |
NA |
NA |
500000 |
NA |
NA |
TTD |
| POLA1 |
2-[(3S,10R,13R,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy]-ethanol |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| POLB |
Plakevulin A |
NA |
179000 |
NA |
NA |
NA |
NA |
BindingDB |
| POLB |
4,7-Dihydroxy-6-methoxy-3-[(2-oxochromen-7-yl)methyl]chromen-2-one |
NA |
122300 |
NA |
NA |
NA |
NA |
BindingDB |